Tag: MRK

Finance

Fast Moving Stocks : Merck (NYSE:MRK), Pfizer (NYSE:PFE), EVV, CEVA Inc. (NASDAQ:CEVA), Mesabi (NYSE:MSB)

Merck & Co. Inc. (NYSE:MRK) has won federal approval for a new type of sleeping pill designed to help people with insomnia stay asleep. Merck & Co. Inc. (NYSE:MRK) belongs to Healthcare sector. Its net profit margin is 12.90% and weekly performance is 5.64%. On last trading day company shares ended up $58.78. Merck & Co. Inc. (NYSE:MRK) distance from 50-day simple moving average (SMA50) … Continue reading Fast Moving Stocks : Merck (NYSE:MRK), Pfizer (NYSE:PFE), EVV, CEVA Inc. (NASDAQ:CEVA), Mesabi (NYSE:MSB)

Colin Pettis
Finance

Active Stocks to Watch : Merck (NYSE:MRK), Kodiak Oil & Gas (NYSE:KOG), Consolidated Water (NASDAQ:CWCO), ConnectOne Bancorp (NASDAQ:CNOB), Terex (NYSE:TEX)

Merck (NYSE:MRK), which has recently faced a number of patent expirations, on Tuesday reported Q2 sales that slowed for an eighth quarter in a row. But earnings climbed 1% to 85 cents a share for its third straight quarter of gains. Merck & Co. Inc. (NYSE:MRK)’s stock on 01 August traded at beginning with a price of $57.76 and when day-trade ended the stock finally advanced … Continue reading Active Stocks to Watch : Merck (NYSE:MRK), Kodiak Oil & Gas (NYSE:KOG), Consolidated Water (NASDAQ:CWCO), ConnectOne Bancorp (NASDAQ:CNOB), Terex (NYSE:TEX)

Kristen Barton
Finance

Healthcare Active Movers: Pfizer Inc. (NYSE:PFE), MannKind Corporation (NASDAQ:MNKD), Gilead Sciences (NASDAQ:GILD), Agenus (NASDAQ:AGEN), Merck & Co (NYSE:MRK)

Spirits maker Diageo North America and pharmaceutical giant Pfizer Inc. (NYSE:PFE) have each agreed to pay a $5,000 fine because their lobbyists failed to disclose expenditures for receptions at the 2012 Democratic National Convention, the Office of State Ethics announced. Pfizer Inc. (NYSE:PFE) stock performance was 1.35% in last session and finished the day at $30.08. Traded volume was 25.60million shares in the last session … Continue reading Healthcare Active Movers: Pfizer Inc. (NYSE:PFE), MannKind Corporation (NASDAQ:MNKD), Gilead Sciences (NASDAQ:GILD), Agenus (NASDAQ:AGEN), Merck & Co (NYSE:MRK)

Kristen Barton
Finance

Healthcare Active Movers: Geron Corporation (NASDAQ:GERN), Merck (NYSE:MRK), Valeant Pharmaceuticals (NYSE:VRX), Johnson & Johnson (NYSE:JNJ), Novavax (NASDAQ:NVAX)

Geron Corporation (NASDAQ:GERN) was one of the Nasdaq’s most active movers, jumping 23 per cent to $3.20 on heavy volume after the US Food and Drug Administration lifted a partial clinical hold on a study testing its blood cancer drug. Geron Corporation (NASDAQ:GERN) stock performance was 21.15% in last session and finished the day at $3.15. Traded volume was 47.60million shares in the last session … Continue reading Healthcare Active Movers: Geron Corporation (NASDAQ:GERN), Merck (NYSE:MRK), Valeant Pharmaceuticals (NYSE:VRX), Johnson & Johnson (NYSE:JNJ), Novavax (NASDAQ:NVAX)

Jayne Crisman
Finance

Healthcare Active Movers: Zogenix, Inc. (NASDAQ:ZGNX), Orexigen Therapeutics (NASDAQ:OREX), Merck & Co (NYSE:MRK), Boston Scientific Corporation (NYSE:BSX), Bristol-Myers Squibb (NYSE:BMY)

Zogenix, Inc (NASDAQ:ZGNX) CEO Roger Hawley unloaded 25,078 shares of the company’s stock on the open market in a transaction that occurred on Tuesday, June 3rd. The shares were sold at an average price of $2.10, for a total transaction of $52,663.80. Following the completion of the sale, the chief executive officer now directly owns 1,204,447 shares in the company, valued at approximately $2,529,339. Zogenix, … Continue reading Healthcare Active Movers: Zogenix, Inc. (NASDAQ:ZGNX), Orexigen Therapeutics (NASDAQ:OREX), Merck & Co (NYSE:MRK), Boston Scientific Corporation (NYSE:BSX), Bristol-Myers Squibb (NYSE:BMY)

Richard Atkins
Finance

Notable Movers: Pfizer Inc. (NYSE:PFE), Merck & Co., Inc. (NYSE:MRK), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Bayer AG (ADR) (OTCMKTS:BAYRY)

Pfizer Inc (NYSE:PFE) Insider Geno J. Germano unloaded 30,000 shares of the stock on the open market in a transaction that occurred on Monday, June 2nd. The stock was sold at an average price of $29.68, for a total value of $890,400.00. Following the transaction, the insider now directly owns 263,495 shares of the company’s stock, valued at approximately $7,820,532. Pfizer Inc. (NYSE:PFE) stock performance … Continue reading Notable Movers: Pfizer Inc. (NYSE:PFE), Merck & Co., Inc. (NYSE:MRK), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Bayer AG (ADR) (OTCMKTS:BAYRY)

Jason Knox